UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________________
FORM SD
Specialized Disclosure Report
____________________
Pulse Biosciences, Inc.
(Exact name of registrant as specified in its charter)
____________________
|
|
|
|
|
Delaware |
| 001-37744 |
| 46-5696597 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
3957 Point Eden Way
Hayward, California 94545
(Address of principal executive offices, including zip code)
Sandra A. Gardiner
Executive Vice President and Chief Financial Officer
(510) 906-4600
(Name and telephone number, including area code, of the person to contact in connection with this report)
____________________
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|
|
|
|
| ☒ |
| Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2019 |
Section 1. Conflict minerals disclsosure
Item 1.01 Conflict Minerals Disclosure and Report
A copy of Pulse Biosciences, Inc.’s (the Company’s) Conflict Minerals Report for the reporting period January 1, 2019 to December 31, 2019 is provided as Exhibit 1.01 hereto and is publicly available at www.pulsebiosciences.com. The Company’s determination and related disclosures relating to materials that may come from the Democratic Republic of Congo, the Republic of Congo, the Central African Republic, South Sudan, Uganda, Rwanda, Burundi, Tanzania, Zambia or Angola or from recycled and scrap sources that are included in the Company’s Conflict Minerals Report and incorporated by reference herein
Item 1.02 Exhibit
In accordance with Rule 13p-1, and this Form SD, the Company is hereby filing its Conflict Minerals Report for the calendar year ended December 31, 2019 as Exhibit 1.01 to this report.
Section 2. Exhibits
The following exhibits are filed as part of this report:
Item 2.01 Exhibits
Exhibit 1.01 — 2019 Conflict Minerals Report of Pulse Biosciences, Inc. as required by Items 1.01 and 1.02 of this Form SD.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
| Pulse Biosciences, Inc. | |
|
|
|
| By: | /s/ Sandra A. Gardiner |
|
| Sandra A. Gardiner Chief Financial Officer, Executive Vice President of Finance and Administration, Secretary and Treasurer (Principal Financial and Accounting Officer) |
Date: May 29, 2020
EXHIBIT INDEX
|
|
| ||
Exhibit No. |
| Description | ||
1.01 |
| |||
|
|
| ||
